Anika Therapeutics Inc ANIK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ANIK is a good fit for your portfolio.
News
-
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
-
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
-
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
-
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
-
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
Trading Information
- Previous Close Price
- $25.69
- Day Range
- $25.37–25.81
- 52-Week Range
- $16.54–28.58
- Bid/Ask
- $10.18 / $40.43
- Market Cap
- $377.63 Mil
- Volume/Avg
- 83,322 / 83,666
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.24
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 1.32%
Company Profile
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 357
- Website
- https://www.anika.com
Comparables
Valuation
|
Metric
|
ANIK
|
NARI
|
ATEC
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 415.02 | — |
Price/Book Value | 1.76 | 4.80 | 22.01 |
Price/Sales | 2.24 | 4.44 | 3.10 |
Price/Cash Flow | 36.06 | 65.88 | — |
Price/Earnings
ANIK
NARI
ATEC
Financial Strength
|
Metric
|
ANIK
|
NARI
|
ATEC
|
|---|---|---|---|
Quick Ratio | 3.50 | 2.43 | 1.86 |
Current Ratio | 5.26 | 3.09 | 2.86 |
Interest Coverage | — | −56.99 | −10.23 |
Quick Ratio
ANIK
NARI
ATEC
Profitability
|
Metric
|
ANIK
|
NARI
|
ATEC
|
|---|---|---|---|
Return on Assets (Normalized) | −1.35% | 5.07% | −9.89% |
Return on Equity (Normalized) | −1.65% | 6.37% | — |
Return on Invested Capital (Normalized) | −2.24% | 3.35% | −9.94% |
Return on Assets
ANIK
NARI
ATEC
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Xkrqwtnrkn | Yqg | $132.1 Bil | |
BDX
| Becton Dickinson & Co | Lprgwxj | Xpdzn | $67.4 Bil | |
ALC
| Alcon Inc | Ctlvxxcb | Zsdyf | $39.1 Bil | |
CLPBY
| Coloplast A/S ADR | Yhqnpfyx | Sslcv | $28.8 Bil | |
WST
| West Pharmaceutical Services Inc | Wmsphhhfh | Vgjkb | $27.6 Bil | |
RMD
| ResMed Inc | Sbnptqps | Knljfj | $26.1 Bil | |
BAX
| Baxter International Inc | Nhpvwqmlw | Jqngms | $20.1 Bil | |
COO
| The Cooper Companies Inc | Zpsmyvr | Wdttft | $18.0 Bil | |
HOLX
| Hologic Inc | Mhrkhkzy | Myzfxx | $17.6 Bil | |
TFX
| Teleflex Inc | Gtn | Wdv | $9.8 Bil |